Gilda Radner Hereditary Cancer Program

What is the Purpose of this Study?

The purpose of this study is to identify factors that influence cancer risk and to better understand the precursors to cancer so that preventive steps can be employed for individuals with and without inherited genetic mutations. Researchers also aim to develop a better understanding about which modifiers (a gene that changes the effect produced by another gene) cause some individuals to be at more risk for developing cancer. The study will collect information about personal and family history of cancer, along with personal demographics, medical history, lifestyle habits, and quality of life.


Eligibility

Not Available


Where can I participate?

  • CS Cancer at Cedars-Sinai Medical Center



What is the full name of this clinical trial?

The Gilda Radner Hereditary Cancer Program

Study Details
Disease Type/Condition

Hereditary Cancer

Principal Investigator

Rimel, Bobbie Jo

Co-Investigators

Alice Chung, Andrew Li, Armando Giuliano, Barry Rosenbloom, Catherine Dang, Christine Walsh, Dorothy Park, Edward Phillips, Farin Amersi, Greg Sarna, Marc Goodman, Michael Van Scoy-Mosher, Michelle Jones, Monica Mita, Philomena McAndrew, Ronald Leuchter, Scott Karlan

Age Group

Adult

Phase

N/A

IRB Number

1080


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Hereditary Cancer

Principal Investigator

Rimel, Bobbie Jo

Age Group

Adult

Phase

N/A

IRB Number

1080


Contact
Email
clinicaltrials@cshs.org